The red face: Dermatomyositis
Identifieur interne : 002D19 ( Main/Exploration ); précédent : 002D18; suivant : 002D20The red face: Dermatomyositis
Auteurs : Marcus R. Stonecipher [États-Unis] ; Jeffrey P. Callen [États-Unis] ; Joseph L. Jorizzo [États-Unis]Source :
- Clinics in Dermatology [ 0738-081X ] ; 1993.
English descriptors
- Teeft :
- Abnormality, Acad dermatol, Acta neurol, Adult patients, Antinuclear antibody, Arch dermatol, Arch intern, Arthritis, Arthritis rheum, Autoantibody, Biopsy, Bohan, Bony prominences, Calcinosis, Callen, Cardiac, Cardiac disease, Chest radiographs, Childhood dermatomyositis, Clin, Clinic, Clinical features, Clinical manifestations, Complete history, Conduction defects, Congestive heart failure, Connective tissue disease, Corticosteroid, Corticosteroid dosage, Corticosteroid therapy, Creatine, Creatine kinase, Current time, Cutaneous, Cutaneous disease, Cutaneous lesions, Dermatol, Dermatology, Dermatology callen, Dermatomyositis, Dermatomyositis rheum, Disease process, Dysphagia, Eruption, Erythematosus, Esophageal involvement, Greater risk, Heliotrope eruption, Immunosuppressive, Immunosuppressive agent, Immunosuppressive agents, Immunosuppressive therapy, Inflammatory, Inflammatory myopathy, Inflammatory myositis, Intern, Internal malignancy, Interstitial lung disease, Intramuscular injections, Jorizzo, Jorizzo clinics, Juvenile dermatomyositis, Laboratory abnormalities, Lesion, Liver biopsy, Lower frequency, Lung disease, Lupus, Lupus erythematosus, Malignancy, Malignant, Malignant disease, Malignant lesions, Mayo clin proc, Methotrexate, Multiple patients, Multiple side effects, Muscle biopsy, Muscle damage, Muscle disease, Muscle enzymes, Muscle weakness, Myopathy, Myositis, Nailfold capillary microscopy, Nailfold changes, Nuclear protein, Overlap category, Overlap syndromes, Papular lesions, Pathogenetic mechanisms, Periungual telangiectasias, Physical examination, Plasma exchange, Poikiloderma, Poikilodermatous eruption, Polymyositis, Poor prognosis, Poor prognostic sign, Poorer prognosis, Prognosis, Prognostic factors, Pulmonary disease, Pulmonary fibrosis, Pulmonary function testing, Pulmonary involvement, Reichlin, Rheum, Rheumatoid arthritis, Semin arthritis rheum, Serum levels, Serum multiphasic analysis, Several authors, Several studies, Skin change, Skin disease, Skin lesions, Stonecipher, Striated muscle, Syndrome, Systemic corticosteroids, Tissue disease, Tissue diseases, Wake forest university.
Abstract
Abstract: Dermatomyositis (DM) is a disease that manifests as an inflammatory myopathy typically producing a symmetric proximal muscle weakness and a characteristic cutaneous eruption.1–3 This disorder is closely related to polymyositis (PM), which has all the clinical features of DM without the presence of skin disease. Both of these disorders are of unknown etiology, but pathogenetic mechanisms are believed to involve immunologically mediated muscle damage.4 Both DM and PM may occur in the presence of other collagen vascular diseases such as lupus erythematosus, scleroderma, Sjögren's syndrome, rheumatoid arthritis, and various vasculitides. Dermatomyositis seems to be characterized by an increased frequency of internal malignancy, whereas malignancy association in patients with PM is less clearly established. Recent data suggest that PM, as well as DM, occurs in children. Both DM and PM are associated with morbidity and mortality and, therefore, prompt and aggressive therapy is necessary. In this review we emphasize practical clinical aspects of DM.
Url:
DOI: 10.1016/0738-081X(93)90062-H
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000571
- to stream Istex, to step Curation: 000571
- to stream Istex, to step Checkpoint: 001A99
- to stream Main, to step Merge: 002D84
- to stream Main, to step Curation: 002D19
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>The red face: Dermatomyositis</title><author><name sortKey="Stonecipher, Marcus R" sort="Stonecipher, Marcus R" uniqKey="Stonecipher M" first="Marcus R." last="Stonecipher">Marcus R. Stonecipher</name></author><author><name sortKey="Callen, Jeffrey P" sort="Callen, Jeffrey P" uniqKey="Callen J" first="Jeffrey P." last="Callen">Jeffrey P. Callen</name></author><author><name sortKey="Jorizzo, Joseph L" sort="Jorizzo, Joseph L" uniqKey="Jorizzo J" first="Joseph L." last="Jorizzo">Joseph L. Jorizzo</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:84B53C16D0070E489D370448AC96D02D744907BB</idno><date when="1993" year="1993">1993</date><idno type="doi">10.1016/0738-081X(93)90062-H</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-83KKCKCW-2/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000571</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000571</idno><idno type="wicri:Area/Istex/Curation">000571</idno><idno type="wicri:Area/Istex/Checkpoint">001A99</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001A99</idno><idno type="wicri:doubleKey">0738-081X:1993:Stonecipher M:the:red:face</idno><idno type="wicri:Area/Main/Merge">002D84</idno><idno type="wicri:Area/Main/Curation">002D19</idno><idno type="wicri:Area/Main/Exploration">002D19</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">The red face: Dermatomyositis</title><author><name sortKey="Stonecipher, Marcus R" sort="Stonecipher, Marcus R" uniqKey="Stonecipher M" first="Marcus R." last="Stonecipher">Marcus R. Stonecipher</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Department of Dermatology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Callen, Jeffrey P" sort="Callen, Jeffrey P" uniqKey="Callen J" first="Jeffrey P." last="Callen">Jeffrey P. Callen</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Department of Dermatology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Jorizzo, Joseph L" sort="Jorizzo, Joseph L" uniqKey="Jorizzo J" first="Joseph L." last="Jorizzo">Joseph L. Jorizzo</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Department of Dermatology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinics in Dermatology</title><title level="j" type="abbrev">CID</title><idno type="ISSN">0738-081X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1993">1993</date><biblScope unit="volume">11</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="261">261</biblScope><biblScope unit="page" to="273">273</biblScope></imprint><idno type="ISSN">0738-081X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0738-081X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abnormality</term><term>Acad dermatol</term><term>Acta neurol</term><term>Adult patients</term><term>Antinuclear antibody</term><term>Arch dermatol</term><term>Arch intern</term><term>Arthritis</term><term>Arthritis rheum</term><term>Autoantibody</term><term>Biopsy</term><term>Bohan</term><term>Bony prominences</term><term>Calcinosis</term><term>Callen</term><term>Cardiac</term><term>Cardiac disease</term><term>Chest radiographs</term><term>Childhood dermatomyositis</term><term>Clin</term><term>Clinic</term><term>Clinical features</term><term>Clinical manifestations</term><term>Complete history</term><term>Conduction defects</term><term>Congestive heart failure</term><term>Connective tissue disease</term><term>Corticosteroid</term><term>Corticosteroid dosage</term><term>Corticosteroid therapy</term><term>Creatine</term><term>Creatine kinase</term><term>Current time</term><term>Cutaneous</term><term>Cutaneous disease</term><term>Cutaneous lesions</term><term>Dermatol</term><term>Dermatology</term><term>Dermatology callen</term><term>Dermatomyositis</term><term>Dermatomyositis rheum</term><term>Disease process</term><term>Dysphagia</term><term>Eruption</term><term>Erythematosus</term><term>Esophageal involvement</term><term>Greater risk</term><term>Heliotrope eruption</term><term>Immunosuppressive</term><term>Immunosuppressive agent</term><term>Immunosuppressive agents</term><term>Immunosuppressive therapy</term><term>Inflammatory</term><term>Inflammatory myopathy</term><term>Inflammatory myositis</term><term>Intern</term><term>Internal malignancy</term><term>Interstitial lung disease</term><term>Intramuscular injections</term><term>Jorizzo</term><term>Jorizzo clinics</term><term>Juvenile dermatomyositis</term><term>Laboratory abnormalities</term><term>Lesion</term><term>Liver biopsy</term><term>Lower frequency</term><term>Lung disease</term><term>Lupus</term><term>Lupus erythematosus</term><term>Malignancy</term><term>Malignant</term><term>Malignant disease</term><term>Malignant lesions</term><term>Mayo clin proc</term><term>Methotrexate</term><term>Multiple patients</term><term>Multiple side effects</term><term>Muscle biopsy</term><term>Muscle damage</term><term>Muscle disease</term><term>Muscle enzymes</term><term>Muscle weakness</term><term>Myopathy</term><term>Myositis</term><term>Nailfold capillary microscopy</term><term>Nailfold changes</term><term>Nuclear protein</term><term>Overlap category</term><term>Overlap syndromes</term><term>Papular lesions</term><term>Pathogenetic mechanisms</term><term>Periungual telangiectasias</term><term>Physical examination</term><term>Plasma exchange</term><term>Poikiloderma</term><term>Poikilodermatous eruption</term><term>Polymyositis</term><term>Poor prognosis</term><term>Poor prognostic sign</term><term>Poorer prognosis</term><term>Prognosis</term><term>Prognostic factors</term><term>Pulmonary disease</term><term>Pulmonary fibrosis</term><term>Pulmonary function testing</term><term>Pulmonary involvement</term><term>Reichlin</term><term>Rheum</term><term>Rheumatoid arthritis</term><term>Semin arthritis rheum</term><term>Serum levels</term><term>Serum multiphasic analysis</term><term>Several authors</term><term>Several studies</term><term>Skin change</term><term>Skin disease</term><term>Skin lesions</term><term>Stonecipher</term><term>Striated muscle</term><term>Syndrome</term><term>Systemic corticosteroids</term><term>Tissue disease</term><term>Tissue diseases</term><term>Wake forest university</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Dermatomyositis (DM) is a disease that manifests as an inflammatory myopathy typically producing a symmetric proximal muscle weakness and a characteristic cutaneous eruption.1–3 This disorder is closely related to polymyositis (PM), which has all the clinical features of DM without the presence of skin disease. Both of these disorders are of unknown etiology, but pathogenetic mechanisms are believed to involve immunologically mediated muscle damage.4 Both DM and PM may occur in the presence of other collagen vascular diseases such as lupus erythematosus, scleroderma, Sjögren's syndrome, rheumatoid arthritis, and various vasculitides. Dermatomyositis seems to be characterized by an increased frequency of internal malignancy, whereas malignancy association in patients with PM is less clearly established. Recent data suggest that PM, as well as DM, occurs in children. Both DM and PM are associated with morbidity and mortality and, therefore, prompt and aggressive therapy is necessary. In this review we emphasize practical clinical aspects of DM.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Caroline du Nord</li></region></list><tree><country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Stonecipher, Marcus R" sort="Stonecipher, Marcus R" uniqKey="Stonecipher M" first="Marcus R." last="Stonecipher">Marcus R. Stonecipher</name></region><name sortKey="Callen, Jeffrey P" sort="Callen, Jeffrey P" uniqKey="Callen J" first="Jeffrey P." last="Callen">Jeffrey P. Callen</name><name sortKey="Jorizzo, Joseph L" sort="Jorizzo, Joseph L" uniqKey="Jorizzo J" first="Joseph L." last="Jorizzo">Joseph L. Jorizzo</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D19 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002D19 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:84B53C16D0070E489D370448AC96D02D744907BB
|texte= The red face: Dermatomyositis
}}
| This area was generated with Dilib version V0.6.33. |  |